Updated: April 9, 2026
How to Help Your Patients Save Money on Tazorac: A Provider's Guide to Savings Programs
Author
Peter Daggett

Summarize with AI
- Understanding the Cost Landscape for Tazarotene in 2026
- Strategy 1: Default to Generic Tazarotene
- Strategy 2: Proactively Share Discount Card Information
- Strategy 3: Use Manufacturer Copay Cards for Eligible Patients
- Strategy 4: Refer Uninsured/Underinsured Patients to Patient Assistance Programs
- Strategy 5: Address Prior Authorization Efficiently
- When Tazarotene Remains Out of Reach: Affordable Alternatives
A practical guide for dermatologists and prescribers on helping patients reduce Tazorac out-of-pocket costs through generics, copay programs, and patient assistance.
Writing the right prescription is only step one. If your patient can't afford to fill it, treatment never happens. Tazarotene is one of dermatology's most effective topical retinoids — but brand-name Tazorac can cost $250–$600 per tube at retail, and even generic tazarotene can run $40–$150 without a coupon. Cost-related non-adherence is measurable and preventable.
This guide outlines the concrete strategies providers can incorporate into their tazarotene prescribing workflow to minimize cost barriers and improve patient adherence.
Understanding the Cost Landscape for Tazarotene in 2026
Before recommending savings strategies, understand the price points your patients face:
Brand-name Tazorac (cream or gel): $250–$600 per 30g tube at retail
Generic tazarotene (retail, no coupon): $40–$150 per 30g tube depending on pharmacy
Generic tazarotene (GoodRx/SingleCare coupon): $40–$80 per 30g tube at most chains
With AbbVie manufacturer copay card (commercial insurance): $0–$35 per fill
With AbbVie patient assistance (uninsured, qualifying income): $0 (medication provided at no charge)
Strategy 1: Default to Generic Tazarotene
The most impactful prescribing decision you can make is writing for generic tazarotene rather than brand-name Tazorac. The drugs are bioequivalent — same active ingredient, same concentration, same clinical effect. There is rarely a clinical justification for brand over generic.
Practical EHR recommendations:
Write "tazarotene" (INN) rather than "Tazorac" in your prescription
Verify the DAW (dispense as written) box is unchecked
Specify formulation (cream vs. gel) and strength (0.05% vs. 0.1%) clearly to avoid dispensing confusion
Strategy 2: Proactively Share Discount Card Information
Most patients don't know that prescription discount cards exist or that they may beat their insurance copay. Make sharing this information a routine part of prescribing dermatology medications:
GoodRx (goodrx.com): Generic tazarotene typically $40–$80 per 30g tube. Free to use, no membership.
SingleCare (singlecare.com): Accepted at CVS, Walgreens, Walmart, and other chains. Free to use.
Optum Perks, RxSaver, BuzzRx: Additional comparison platforms worth recommending to patients who are price-comparing.
Consider printing a simple one-page "savings options" handout or directing patients to a trusted savings guide. Many dermatology practices include this in their checkout or patient portal.
Strategy 3: Use Manufacturer Copay Cards for Eligible Patients
For commercially insured patients who need brand Tazorac for a specific clinical reason (rare), the Allergan/AbbVie savings card can reduce out-of-pocket cost to $0–$35 per fill.
Key eligibility restrictions:
Commercial insurance only — cards cannot be used with Medicare, Medicaid, TRICARE, or other government programs
Must fill at a participating retail pharmacy
Program terms and annual benefit caps may vary; check current program details at the Allergan/AbbVie website
Strategy 4: Refer Uninsured/Underinsured Patients to Patient Assistance Programs
For uninsured patients who cannot afford even generic tazarotene, the AbbVie Patient Assistance Foundation (APAF) may provide brand-name Tazorac at no cost. Eligibility is income-based. Your office can assist patients with applications, or direct them to:
AbbVie Patient Assistance Foundation (abbvie.com/access-and-affordability.html)
NeedyMeds.org — comprehensive database of patient assistance programs
RxAssist.org — another searchable PAP database
Strategy 5: Address Prior Authorization Efficiently
Insurance prior authorization is often required for tazarotene, and delays in PA approval translate directly to treatment gaps and cost anxiety for patients. Minimize this burden:
Run a real-time benefits check at the point of prescribing to identify PA requirements before sending the Rx
Build a templated PA letter in your EHR that includes: diagnosis (ICD-10), prior therapy tried/failed, clinical rationale for tazarotene, duration of condition, and relevant exam findings
Provide a bridge prescription (tretinoin or adapalene) while PA is pending to ensure the patient is not going untreated
When Tazarotene Remains Out of Reach: Affordable Alternatives
When cost remains a barrier even after exhausting the above strategies, consider these therapeutic alternatives:
Adapalene 0.1% OTC (Differin): ~$10–$15 per tube, no prescription needed; effective for mild-moderate acne
Generic tretinoin: $20–$80 with coupon; widely covered; evidence-based for acne and photoaging
Topical corticosteroids (for psoriasis): Generic clobetasol 0.05% costs $10–$30; widely covered; appropriate first-line bridge
When patients are struggling to locate filled prescriptions at local pharmacies, medfinder for providers helps patients find which local pharmacies have their medication in stock, reducing unnecessary delays between prescription and treatment.
For the complete pharmacy access guide for providers, see: How to Help Your Patients Find Tazorac in Stock: A Provider's Guide.
Frequently Asked Questions
Prescribe generic tazarotene in virtually all cases. It is FDA-approved as bioequivalent to brand Tazorac and costs dramatically less — $40–$80 with a GoodRx coupon versus $250–$600 for brand. There is rarely a clinical reason to mandate the brand formulation. Ensure the DAW box is unchecked and write "tazarotene" (the INN) rather than the brand name.
No. Federal anti-kickback regulations prohibit the use of manufacturer copay cards (including Allergan/AbbVie's Tazorac savings card) with Medicare, Medicaid, TRICARE, or other government-funded insurance programs. For Medicare patients, compare Part D formulary pricing and recommend third-party discount cards like GoodRx, which are not prohibited.
File an appeal with the plan's medical director, including detailed clinical documentation of diagnosis, prior treatment failures, and the clinical necessity for tazarotene. Most denials are overturned on appeal with a well-documented letter of medical necessity. While the appeal is pending, provide the patient with a bridge prescription for tretinoin or adapalene to maintain treatment continuity.
Yes. The AbbVie Patient Assistance Foundation may provide brand-name Tazorac at no cost to qualifying uninsured or underinsured patients who meet income requirements. NeedyMeds.org and RxAssist.org also list available programs. For commercially insured patients, Allergan/AbbVie copay savings cards can reduce out-of-pocket costs to $0–$35 per fill.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Tazorac also looked for:
More about Tazorac
33,257 have already found their meds with Medfinder.
Start your search today.





